Ikarian Capital, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$272,093
-99.3%
32,547
-98.0%
0.03%
-99.5%
Q2 2023$41,040,648
+195331.7%
1,652,200
+71985.5%
6.54%
+217766.7%
Q1 2022$21,000
-99.4%
2,292
-98.9%
0.00%
-99.5%
Q4 2021$3,787,000
+15.4%
199,339
+102.2%
0.56%
+144.2%
Q3 2021$3,282,000
-15.4%
98,600
-1.4%
0.23%
-26.2%
Q2 2021$3,878,000
-19.5%
100,0000.0%0.31%
+93.2%
Q1 2021$4,820,000
-7.3%
100,0000.0%0.16%
-29.3%
Q4 2020$5,202,000
+48.2%
100,000
-68.4%
0.23%
-59.8%
Q4 2019$3,510,000316,2000.57%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders